Kathy Oliver

Advocacy in Action ESMO 2012: Advocate Perspectives in Tissue Collection and Research
Dec
18
2012

Selma Schimmel (Vital Options International), Kathy Oliver (International Brain Tumor Alliance), Francesco De Lorenzo (European Cancer Patient Coalition), Jola Gore Booth (EuropaColon) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss tissue collection in cancer research. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, [...]

Read More
Advocacy in Action ESMO 2012: The Challenges Of Genetic Marker Testing Requirements
Dec
18
2012

Kathy Oliver (International Brain Tumor Alliance), Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the challenges of the genetic marker testing requirements for patients. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in [...]

Read More
Improving Clinical Trials Information in Europe
Oct
28
2011

Vital Options presents Advocacy in Action (AIA), in partnership with the ESMO Cancer Patient Working Group and in collaboration with the ECCO Patient Advisory Committee. This six-part AIA Forum brings together influential leaders in cancer advocacy, to address the core issues that impact cancer survivorship. Joining Vital Options CEO, Selma Schimmel, will be AIA co-chair [...]

Read More
Creating National Cancer Plans in Europe
Oct
28
2011

Vital Options presents Advocacy in Action (AIA), in partnership with the ESMO Cancer Patient Working Group and in collaboration with the ECCO Patient Advisory Committee. This six-part AIA Forum brings together influential leaders in cancer advocacy, to address the core issues that impact cancer survivorship. Joining Vital Options CEO, Selma Schimmel, will be AiA co-chair [...]

Read More